Exploiting protease activation for therapy.

Area of Science:

• Biochemistry and Molecular Biology
• Drug Discovery and Development
• Protease Biology and Therapeutics

Background:

• Proteases play vital roles in maintaining health and in the development of diseases.
• Protease inhibitors and recombinant proteases are established therapeutic agents in enzyme replacement therapy.
• Understanding protease biology is key to developing new treatments across various medical indications.

Purpose of the Study:

• To summarize therapeutic strategies centered on protease activation.
• To focus on novel drug discovery approaches driven by insights into controlled proteolytic activation of growth factors and interleukins.
• To cover emerging therapeutic strategies involving antibody-based and engineered protein therapies.

Main Methods:

• Review of current literature on protease activation in therapeutics.
• Analysis of emerging strategies targeting the proteolytic activation process.
• Focus on antibody therapies and engineered pro-form biopharmaceuticals.

Main Results:

• Recent insights into spatial and temporal control of proteolytic activation are enabling new drug discovery.
• Emerging strategies include antibody therapies targeting pro-form activation and engineered, activatable biopharmaceuticals.
• These approaches aim to increase specificity and improve the therapeutic window.

Conclusions:

• Targeting the proteolytic activation of proteins offers unique opportunities for novel medicine discovery.
• Antibody therapies and engineered pro-form proteins represent promising new classes of biopharmaceuticals.
• These advanced strategies have the potential to significantly improve therapeutic outcomes by enhancing specificity and safety.